Clinical Trials Browser

Biliary Tract Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Biliary Tract Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence

Metastatic Adenocarcinoma of the Pancreas

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Pancreatic Neoplasms

Pancreatic cancer, adult

Pancreatic Intraductal Neoplasms

Pancreatic Cancer Metastatic

Pancreatic Neoplasms

Advanced Biliary Tract Cancer

Pancreas Adenocarcinoma

Biliary Tract Neoplasms

Gallbladder Neoplasms, Cholangiocarcinoma

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

Pancreatic Neoplasms

Pancreatic Neoplasms

First-line Treatment of Metastatic Pancreatic Cancer

Pancreatic Neoplasms

Locally Advanced Pancreatic Cancer

Pancreatic Neoplasms

Pancreatic Cancer Resectable

Cholangiocarcinoma

Pancreatic Adenocarcinoma

Biliary Tract Neoplasms

Biliary Tract Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Pancreatic Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Cholangiocarcinoma

Biliary Tract Neoplasms

Pancreatic Neoplasms

Gallbladder Neoplasms, Cholangiocarcinoma

Locally Advanced Pancreatic Cancer

Biliary Tract Neoplasms

Pancreatic Cancer Non-resectable

Pancreatic Neoplasms

Endocrine Gland Neoplasms, Jaundice, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Carcinoma, Hepatocellular, Hepatoblastoma

First-line Treatment of Advanced Pancreatic Cancer

Cholangiocarcinoma

Pancreatic Neoplasms

Pancreatic Neoplasms

Clinical Trials

DESTINY-BTC01

KEYNOTE-966

LAP100

RASolute 303

PRISM-1

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

TOURMALINE

KEYNOTE-966

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

AB02

NAPOLI 3

Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

pompom

A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

AK112 Combined With Chemotherapy Versus Durvalumab Combined With Chemotherapy in Advanced Biliary Tract Cancer

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

PTCA199-16

RASolute 302

Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

TIGeR-PaC

A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer

LEFT-PANC

FIGHT-302

PTCA199-11

TAB-2

KN035-BTC

PANThEON

Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer

MAESTRO

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

SAFIR-ABC10

A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

ACTICCA-1

Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer

GAIN

LAPIS

Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer

GAMMA

PHITT

HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer

Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations

CONKO-007

A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer